DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Pexelizumab
Pexelizumab
Fig. L COMPOSITIONS and METHODS to INHIBIT STEM CELL and PROGENITOR CELL BINDING to LYMPHOID TISSUE and for REGENERATING GERMINAL CENTERS in LYMPHATIC TISSUES
Modifications to the Harmonized Tariff Schedule of the United States To
Ep 3178848 A1
I Regulations
INN Working Document 05.179 Update 2011
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
IUPAC Glossary of Terms Used in Immunotoxicology (IUPAC Recommendations 2012)*
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
(INN) for Biological and Biotechnological Substances
WO 2018/067987 Al 12 April 2018 (12.04.2018) W !P O PCT
WHO Drug Information Vol
WO 2014/145208 Al 18 September 2014 (18.09.2014) P O P C T
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
(12) United States Patent (10) Patent No.: US 9,682,071 B2 Nicols Et Al
Wo 2010/095940 A2
Antibody-Drug Analogues
An Overview of the Current Status of Engineered Therapeutic Monoclonal Antibodies
Assessment of the Evolution of Cancer Treatment Therapies
Top View
Antibody Fragments and Their Purification by Protein L Affinity Chromatography
Pharmaabkommen A1 E
Customs Tariff - Schedule Xxi - 1
ALEXION Pharmaceuticals™ Antibody Therapy Shown Effective in Model for Severe Allergic Asthma
Inhibition of Complement Activation in Cardiac Surgery
(12) Patent Application Publication (10) Pub. No.: US 2010/0173323 A1 Strome Et Al
WO 2012/160186 Al 29 November 2012 (29.11.2012) P O P C T
Esophagitis: Drugs Picture of Iron Pill Material in Biopsy TT’S Kodachrome 1St Page Folder Iron Medication Injury Medications/Drugs
Immunomodulatory Treatment for the Intractable Paediatric Epilepsies Luis E
(INN) for Biological and Biotechnological Substances
Thalidomide - Wikipedia, the Free Encyclopedia
Assessment of the Evolution of Cancer Treatment Therapies
WO 2013/120629 Al 22 August 2013 (22.08.2013) P O P C T
Part III the Delicate Balance of the Immune System Between Tolerance
International Nonproprietary Names (INN) for Biological and Biotechnological Substances